Clinical Trial: Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial

U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473427) titled 'Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial' on March 11.

Brief Summary: This is a single armed, Phase 3 study to assess the immunogenicity and safety of the varicella vaccine manufactured by Sinovac. A total of 300 healthy participants aged 1-12 years will be enrolled. All participants will receive a single dose of varicella vaccine manufactured by Sinovac.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Varicella (Chickenpox) Varicella Immunisation

Intervention: BIOLOGICAL: Varicella Vaccine

Varicella vaccine manu...